1. Atypical brain FDG-PET patterns increase the risk of long-term cognitive and motor progression in Parkinson's disease
- Author
-
Imarisio, A, Pilotto, A, Premi, E, Caminiti, S, Presotto, L, Sala, A, Zatti, C, Lupini, A, Turrone, R, Paghera, B, Borroni, B, Perani, D, Padovani, A, Imarisio A., Pilotto A., Premi E., Caminiti S. P., Presotto L., Sala A., Zatti C., Lupini A., Turrone R., Paghera B., Borroni B., Perani D., Padovani A., Imarisio, A, Pilotto, A, Premi, E, Caminiti, S, Presotto, L, Sala, A, Zatti, C, Lupini, A, Turrone, R, Paghera, B, Borroni, B, Perani, D, Padovani, A, Imarisio A., Pilotto A., Premi E., Caminiti S. P., Presotto L., Sala A., Zatti C., Lupini A., Turrone R., Paghera B., Borroni B., Perani D., and Padovani A.
- Abstract
Introduction: Brain hypometabolism patterns have been previously associated with cognitive decline in Parkinson's disease (PD). Our aim is to evaluate the impact of single-subject fluorodeoxyglucose (FDG)-PET brain hypometabolism on long-term cognitive and motor outcomes in PD. Methods: Forty-nine non-demented PD patients with baseline brain FDG-PET data underwent an extensive clinical follow-up for 8 years. The ability of FDG-PET to predict long-term cognitive and motor progression was evaluated using Cox regression and mixed ANCOVA models. Results: Participants were classified according to FDG-PET pattern in PD with typical (n = 26) and atypical cortical metabolism (n = 23). Patients with atypical brain hypometabolic patterns showed higher incidence of dementia (60% vs 3%; HR = 18.3), hallucinations (56% vs 7%, HR = 7.3) and faster motor decline compared to typical pattern group. Conclusion: This study argues for specific patterns of FDG-PET cortical hypometabolism in PD as a prognostic marker for long term cognitive and motor outcomes at single-subject level.
- Published
- 2023